Repository logo
 

Association of Extended Dosing Intervals or Delays in Pembrolizumab-Based Regimens With Survival Outcomes in Advanced Non-small-cell Lung Cancer

Simple item page
dc.contributor.authorBulumulle, Anushi
dc.contributor.authorBrody, Heather
dc.contributor.authorMacherla, Shravanti
dc.contributor.authorWalker, Paul R.
dc.contributor.authorSehgal, Kartik
dc.contributor.authorGill, Ritu R.
dc.contributor.authorQilleri, Aleksandra
dc.contributor.authorMcDonald, Danielle C.
dc.contributor.authorCherry, Cynthia R.
dc.contributor.authorShea, Meghan
dc.contributor.authorHuberman, Mark S.
dc.contributor.authorVanderLaan, Paul A.
dc.contributor.authorWeiss, Glen J.
dc.contributor.authorCosta, Daniel B.
dc.contributor.authorRangachari, Deepa
dc.date.accessioned2022-10-13T18:25:51Z
dc.date.available2022-10-13T18:25:51Z
dc.date.issued2021
dc.identifier.doi10.1016/j.cllc.2020.05.028
dc.identifier.issn1525-7304
dc.identifier.urihttp://hdl.handle.net/10342/11510
dc.language.isoen_USen_US
dc.subjectDosing Intervalsen_US
dc.subjectSurvival Outcomesen_US
dc.subjectNonesmall-cell Lung Canceren_US
dc.titleAssociation of Extended Dosing Intervals or Delays in Pembrolizumab-Based Regimens With Survival Outcomes in Advanced Non-small-cell Lung Canceren_US
dc.typeArticleen_US
ecu.journal.issue3en_US
ecu.journal.nameClinical Lung Canceren_US
ecu.journal.pagese379-e389en_US
ecu.journal.volume22en_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
BulumulleAssociationofExtendedDosingIntervalsorDelaysinPembrolizumabbasedRegimens.pdf
Size:
884.2 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Oncology